Sale by Christopher Ryan Sullivan (Chief Financial Officer)
47,000 shares · @ $20.19 · $948,722
Avalo Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $15.75
-29% in 7d after detection
Post-detection moves
1h
—
1d
-5.7%
3d
-13%
7d
-29%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS